With the approval of drugs like elotuzumab , which helps the immune system fend off cancerous cells in people with multiple myeloma, treating cancers of the blood has never been more promising. Elotuzumab was developed by AbbVie, and Business Insider spoke with Gary Gordon, the company’s vice president of oncology development, about its cancer drugs, and what the future of cancer treatment will look like.
Are you up for a challenge?
